Alexion Pharmaceuticals
Headquartered in Cheshire, Connecticut (USA), Alexion is global biopharmaceutical company focused on the development and delivery of life-transforming therapies for patients with severe and life-threatening rare disorders.
Financial Data
-
31st Dec 17 Source: Estimated
- €3.2 billion turnover
- 300 employees
-
31st Dec 16 Source: Estimated
- €188.1 million turnover
- 500 employees
- 3 more years available »
Ranking
By Turnover
(€3.2 billion)- 32nd in Top Companies
- 7th in Health
- 6th in Pharma
By Employees
(300)- 473rd in Top Companies
- 70th in Health
- 49th in Pharma
- 300
- €3.2 billion
Employees
- Julie O'Neill Senior vice president
Latest News
- 2:09pm No-deal Brexit would be ‘absolutely catastrophic’, Airbus boss warns
- 1:49pm Citigroup makes offer to buy London skyscraper HQ for €1.37 bn
- 1:19pm Seen & Heard: Consultancy companies in firing line over children’s hospital
- Feb 16 UK airline Flybmi blames Brexit uncertainty for its collapse
- Feb 16 Derry airport ‘reviewing options’ over Stansted route as flybmi collapses